Navigation Links
Siemens Medical Solutions Receives CCHIT Certification for Soarian Clinicals With Siemens Pharmacy and Med Administration Check
Date:11/5/2007

committed to developing solutions that help healthcare providers to improve patient safety, optimize workflows and deliver more cost-effective care initiatives," explained Janet Dillione, president, Health Services, the Healthcare IT Division of Siemens Medical Solutions. "We believe this certification clearly demonstrates that our Soarian platform is one such solution that can aid organizations in meeting all of these crucial goals. We look forward to continuing to work with our customers, partners, industry colleagues, and the Certification Commission to drive EHR standardization and information technology adoption."

CCHIT's certification compliance criteria and its design for a certification inspection process have been thoroughly researched, taking into account the state of the art of EHRs and available standards, and comparing certification processes in other industries and other countries.

The inspection process is based on real-life medical scenarios designed to test products rigorously against the clinical needs of providers and the quality and safety needs of healthcare consumers and payers. One script, for example, recreates a scenario of a middle-aged man admitted through the emergency department after sustaining fractures in an automobile accident. The script tests the ability of the EHR to provide clinical decision support during the ordering and administration of medications, and to track whether laboratory and radiology orders have been entered and received.

About Siemens Medical Solutions

Siemens Medical Solutions of Siemens AG (NYSE: SI) is one of the world's largest suppliers to the healthcare industry. The company is known for bringing together innovative medical technologies, health
'/>"/>

SOURCE Siemens Medical Solutions
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Siemens Extends Tender Offer for Acquisition of Dade Behring
2. Siemens Congratulates Kenneth R. Bertka, M.D., Recipient of 2007 AMDIS Award
3. Siemens Announces Early Termination of Hart-Scott-Rodino Waiting Period For Acquisition of Dade Behring Holdings, Inc.; U.S. Antitrust Clearance Achieved
4. MEDRAD Announces eCoil(TM) for Siemens, Philips 3.0T MR Scanners
5. VIDEO from Medialink and Siemens: The Next Generation Allergy Test - Nothing to Sneeze At
6. Siemens Building Technologies Pioneers Wireless Solution for St. Anthonys Sensitive Environment
7. Susquehanna Health and Siemens Announce Plans to Improve Hospital Facilities Through Technology Investment
8. Siemens Medical Solutions Diagnostics Announces the Release of the Rapidlab 1200 Series Version 2.0 Software
9. VIDEO from Medialink and Siemens: Worlds Smallest Ultrasound Package Launches in the U.S.
10. Siemens Soarian Health Information Management is Widely Adopted by Leading Healthcare Institutions in 2007
11. James Cracknell Launches Siemens Stroke for Stroke Week
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...ts may prevent cognitive decline in some, study sa...- Older adults who exercise regularly have increa... brain, a new study shows. , The University of ...ed Monday at the Radiological Society of North Ame...xplain other studies that exercise prevents cognit...
(Date:12/1/2008)... push wraps up successful disaster relief campaign...ire/ -- The American Red Cross is asking people ac...g $30 million in 30 days. This holiday season push... for the Red Cross Campaign for Disaster Relief. A... since its launch in September, and the Red Cross ...
(Date:12/1/2008)... Johnson and Cookie Johnson Public Service Announc...ans , , ABBOTT PARK, Ill., Dec. 1 /PRNewswi... of World AIDS Day, the Magic Johnson Foundation ... themselves, their family and friends about HIV/AI...y. A new social networking tool allows Facebook us...
(Date:12/1/2008)...n., Dec. 1 Medication therapy mana...e accomplished professionals to its,advisory boar...ard include Martin Makary, M.D.;,Michael Burcham;...oup of,advisors that has helped PharmMD launch an...nst medication error, misuse, overuse and abuse. ...
Breaking Medicine News(10 mins):Health News:Red Cross Asks America to Help Raise $30 Million in 30 Days 2Health News:Red Cross Asks America to Help Raise $30 Million in 30 Days 3Health News:Video: Magic Johnson Foundation and Abbott Call for Greater Prevention, Testing and Treatment on World AIDS Day 2Health News:Video: Magic Johnson Foundation and Abbott Call for Greater Prevention, Testing and Treatment on World AIDS Day 3Health News:Video: Magic Johnson Foundation and Abbott Call for Greater Prevention, Testing and Treatment on World AIDS Day 4Health News:Video: Magic Johnson Foundation and Abbott Call for Greater Prevention, Testing and Treatment on World AIDS Day 5Health News:PharmMD Expands Advisory Board 2
... of their value on Wednesday after the company rep...perimental treatment against the hepatitis C virus...ercent, to $4.83, in the heavy morning trade on th...regon based biotechnology company said that the re...
...ontent of beverages such as tea, coffee and soda m...your suspicion about the decaf label that claims r..., produced by researchers at Washington University...sis. The results of the present study have been pu...
... among people. The main reason is the belief that ...vegetables. // But according to a popular magazine...idence to support it. A shot of wheatgrass is$3. C...at wheatgrass became popular due to an American nu...
...the government on HIV/AIDS, tuberculosis and malar...resolution was passed,// declaring that at least 8...should have access to HIV/AIDS treatment such as a...l society organizations were eager to note these t...
Other Medicine News:Health News:Caffeine Content In Beverages To Be Identified By Home Test Kit 2
(Date:11/24/2008)...RNewswire-FirstCall/ -- Leaders of Schering-Plough...te for investors on the company,s research pipelin...at includes 46 new entities in clinical trials or ...ies. , , "Research and development is addin...ntinue our transformation," said Fred Hassan, chai...
(Date:11/24/2008)...ay Unveils Rich Development Pipeline of Compounds ...RTH, N.J., Nov. 24 Scher...ed top-line results of a long-term Phase III clini...(TM) (asenapine) demonstrating efficacy and safety...trial, asenapine was statistically significantly m...
(Date:11/24/2008)... GeneThera, Inc.,(Pink S...ring its Real Time,PCR test for Johne,s disease t... GeneThera is set to begin offering its Johne,s di... According to GeneThera Chairman, Dr. Tony Milici...me PCR test for Johne,s disease,called HerdGuard...
(Date:11/24/2008)..., November 24 NicOx,S.A...the third pivotal phase,3 study for naproxcinod i...tistically significant result (p<0.001) on all ... Naproxcinod 750 mg bid showed the same,gastroint...d pressure profile,to placebo. Naproxcinod is the...
Breaking Medicine Technology:Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 2Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 3Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 4Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 5Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention 2Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention 3GeneThera Announces it is Set to Begin Commercial Testing for Johne's Disease as Soon as January, 2009. 2GeneThera Announces it is Set to Begin Commercial Testing for Johne's Disease as Soon as January, 2009. 3GeneThera Announces it is Set to Begin Commercial Testing for Johne's Disease as Soon as January, 2009. 4Third Pivotal Phase 3 Study for NicOx' Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results 2Third Pivotal Phase 3 Study for NicOx' Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results 3Third Pivotal Phase 3 Study for NicOx' Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results 4Third Pivotal Phase 3 Study for NicOx' Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results 5AGU journal highlights Sept 3 2008 4700 1AGU journal highlights Sept 3 2008 4700 2AGU journal highlights Sept 3 2008 4700 3AGU journal highlights Sept 3 2008 4700 4AGU journal highlights Sept 3 2008 4700 5AGU journal highlights Sept 3 2008 4700 6AGU journal highlights Sept 3 2008 4700 7Demystifying Medicare and Long Term Care Insurance Healthcare Liaison Workshop 9 20 Shows Consumers How to Make Choices 26030 1Demystifying Medicare and Long Term Care Insurance Healthcare Liaison Workshop 9 20 Shows Consumers How to Make Choices 26030 2Inverness Medical Innovations to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 9 2008 7458 1Monitoring immune responses in disease 26024 1
...cussing Pharmacokinetics and Dose Proportionality ...n Biopharmaceutics,Journal -, LAVAL, QC, June 29, ... announced that it will present a poster discussin... of tramadol at the 3rd,International Forum on Pai...ontreal, Canada. , The poster compares two differe...
...ONDON, 2 July,2007: Chi-Med, the Hutchison Whampoa... announces positive results for its Phase II,proof... Ulcerative,Colitis, a form of inflammatory bowel ...-004 was well tolerated and showed an,equivalent d...ug,Mesalazine, the current first-line standard of...
Other Medicine Technology:Labopharm to Present Poster on Dose Titration of Once-daily,Tramadol at 3rd International Forum on Pain Medicine 2Labopharm to Present Poster on Dose Titration of Once-daily,Tramadol at 3rd International Forum on Pain Medicine 3Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 2Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 3Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 4Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 5Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 6Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 7Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 8
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
Medicine Products: